The adoption of IFN-α as the first standard of care to treat chronic HBV infection. ~5-8% of patients respond to IFN-α treatment, which demonstrated the first possibility of treating chronic HBV infection.
1990
1990
The adoption of IFN-α as the first standard of care to treat chronic HBV infection. ~5-8% of patients respond to IFN-α treatment, which demonstrated the first possibility of treating chronic HBV infection.